Skip to main content
Caplight Logo









Facio BioTherapies

Facio BioTherapies

Private
MelbourneHealthcare & Life Scienceshttps://faciobt.com/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Facio BioTherapies is a biotechnology company that develops innovative genetic therapies for facioscapulohumeral muscular dystrophy (FSHD).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

facioscapulohumeral muscular dystrophyFSHDantisense oligonucleotideASOgene silencingRNA therapyrare disease drugneuromuscular diseaseDUX4biotech startupdrug discoveryprecision medicineorphan drugclinical researchmuscle targeting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Facio BioTherapies Comparables

Compare Facio BioTherapies with similar companies based on industry and business-model similarity.

Facio BioTherapies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Armatus Bio
83%
Altay Therapeutics
81%
miRecule, Inc.
80%

Facio BioTherapies Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 650% MoM, reaching 1.6K.

Facio BioTherapies Filings

Explore SEC and related filing metadata, where available.

Facio BioTherapies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Facio BioTherapies's valuation, stock price, and market status.

Is Facio BioTherapies a public or private company?

Facio BioTherapies is a private company.

What is the current stock price of Facio BioTherapies?

Facio BioTherapies is a private company with no public stock price. Caplight tracks Facio BioTherapies's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Facio BioTherapies worth (valuation)?

Valuation information for Facio BioTherapies is not publicly available.

Can I buy Facio BioTherapies stock?

Facio BioTherapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Facio BioTherapies's last funding round?

Funding round information for Facio BioTherapies is not publicly available.

Who are the main investors in Facio BioTherapies?

Investor information for Facio BioTherapies is not publicly disclosed.

Will Facio BioTherapies IPO soon?

No public IPO plans have been announced for Facio BioTherapies.

How can I track Facio BioTherapies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Facio BioTherapies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMelbourne
Employee Range5
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?